http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101859137-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y604-01002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y201-01068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y403-01023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y602-01012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y205-01054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y203-01095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y504-99005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y402-01051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-22 |
| filingDate | 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101859137-B1 |
| titleOfInvention | Recombination vectors for producing Pinostilbene or Pterostilbene |
| abstract | The present invention relates to a recombinant vector for producing pinostilbene or phthalostilbene, a transformant for producing pinostilbene or phthlostilbene, and a process for producing pinostilbene or phthalostilbene. When a recombinant vector for producing a finostilbene or a phthalostilbene according to the present invention is used, pinostilbene or phthalostilbene can be obtained as a single vector system, and through the microbial metabolic pathway, It is economical because it mass-produces stilben. In addition, pinostelbene or ferrostilbene produced by the recombinant vector has anticancer effect, antiinflammatory effect, antihyperlipidemic effect and antioxidative effect, and thus can be usefully used in the pharmaceutical industry. |
| priorityDate | 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 202.